Today is April 28, 2024. All times in Eastern Daylight Time.
Riassunto: HCLTech riferisce un fatturato di 13,3 miliardi per l'esercizio 2024, con un rialzo del 5,4% su base annua
04/26/2024 - 11:33 PM
BUSINESS WIRE
ReNAgade Therapeutics繼續致力於GanNA Bio和糖生物學的研究
04/26/2024 - 11:32 PM
BUSINESS WIRE
ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究
04/26/2024 - 11:32 PM
BUSINESS WIRE
HCLTech informa ingresos por 13.300 millones de dólares para el año fiscal 2024, un aumento interanual del 5,4 %
04/26/2024 - 11:27 PM
BUSINESS WIRE
Samenvatting: ReNAgade Therapeutics gaat verder met GanNA Bio en glycobiology
04/26/2024 - 11:25 PM
BUSINESS WIRE
Resumen: ReNAgade Therapeutics sigue apostando por GanNA Bio y la biología de glucanos
04/26/2024 - 11:25 PM
BUSINESS WIRE
HCLTech informa receita de US$ 13,3 bilhões no ano fiscal de 24, um aumento de 5,4% em relação ao ano anterior
04/26/2024 - 11:19 PM
BUSINESS WIRE
CDC da América Latina é obrigatório, dizem líderes de saúde pública e a AHF
04/26/2024 - 11:02 PM
BUSINESS WIRE
ADTRAN Holdings, Inc. to Meet with Investors at the German Spring Conference 2024 – Equity Forum on May 13-15, 2023
04/26/2024 - 08:05 PM
BUSINESS WIRE
The Law Offices of Frank R. Cruz Announces Investigation of Intel Corporation (INTC) on Behalf of Investors
04/26/2024 - 08:00 PM
BUSINESS WIRE
1
2
3
4
5
6
7
8
9
10
11
...
1403
« Previous
Next »